Ayôla Akim ADEGNIKA
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGOA, Ulysse ATEBA
TB-MR, NCT03057756: Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Recruiting
N/A
23
RoW
Km+ Mfx+ Pto + H + Cfz +E+Z
Centre de Recherche Médicale de Lambaréné, Institute of Tropical Medicine, University of Tuebingen, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Multi-drug Resistant Tuberculosis
04/23
07/23
ADEGNIKA, Ayôla Akim
PamTBVac, NCT05905432: Pan-Malaria Transmission-Blocking Vaccine AnAPN1

Not yet recruiting
1
33
RoW
Vaccine AnAPN1
Centre de Recherche Médicale de Lambaréné, Global Health Innovative Technology Fund
Malaria
12/23
12/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGOA, Ulysse ATEBA
TB-MR, NCT03057756: Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Recruiting
N/A
23
RoW
Km+ Mfx+ Pto + H + Cfz +E+Z
Centre de Recherche Médicale de Lambaréné, Institute of Tropical Medicine, University of Tuebingen, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Multi-drug Resistant Tuberculosis
04/23
07/23
ADEGNIKA, Ayôla Akim
PamTBVac, NCT05905432: Pan-Malaria Transmission-Blocking Vaccine AnAPN1

Not yet recruiting
1
33
RoW
Vaccine AnAPN1
Centre de Recherche Médicale de Lambaréné, Global Health Innovative Technology Fund
Malaria
12/23
12/23

Download Options